Abstract
BackgroundOxaliplatin-related neurotoxicity is the main limitation for its continuation in adjuvant and palliative chemotherapy.PurposeTo evaluate oxaliplatin-related neurotoxicity in combination with other chemotherapeutic agents or radiation in the Department of Medical...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have